Quarterly report pursuant to Section 13 or 15(d)

CONDENDED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENDED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Net revenue $ 86,000 [1] $ 34,000 [1]
Cost of revenue 79,000 21,000
Gross profit 7,000 13,000
Operating expenses:    
Selling and administrative expenses 507,000 269,000
Amortization of prepaid advisory fees 0 411,000
Research and development 121,000 107,000
Total operating expense 628,000 787,000
Operating loss (621,000) (774,000)
Other income (expense):    
Change in fair value of warrant derivative liability 438,000 81,000
Interest expense, net (14,000) (53,000)
Net loss $ (197,000) $ (746,000)
Net loss per common share - basic and diluted $ 0.00 $ (0.02)
Weighted average number of common shares outstanding - basic and diluted 93,857,083 47,493,619
[1] Includes sales to related parties of approximately $0 and $3,000 for the three months ended September 30, 2014 and 2013, respectively.